Akso Health Group
AHG
$1.57
-$0.02-1.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -2.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -2.36% | |||
| Cost of Revenue | 0.00% | 17.12% | |||
| Gross Profit | 0.00% | -201.83% | |||
| SG&A Expenses | 0.00% | -6.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 11.38% | |||
| Operating Income | 0.00% | -78.29% | |||
| Income Before Tax | 0.00% | -1,237.81% | |||
| Income Tax Expenses | 0.00% | -1,230.36% | |||
| Earnings from Continuing Operations | 0.00% | -1,238.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -23.81% | |||
| Net Income | 0.00% | -1,263.54% | |||
| EBIT | 0.00% | -78.29% | |||
| EBITDA | 0.00% | -564.60% | |||
| EPS Basic | 0.00% | -827.27% | |||
| Normalized Basic EPS | 0.00% | -28.57% | |||
| EPS Diluted | 0.00% | -673.33% | |||
| Normalized Diluted EPS | 0.00% | -28.57% | |||
| Average Basic Shares Outstanding | 0.00% | 45.36% | |||
| Average Diluted Shares Outstanding | 0.00% | 45.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||